OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+17.3%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$608M
AUM Growth
+$608M
(-3.3%)
Cap. Flow
-$69.5M
Cap. Flow
% of AUM
-11.44%
Top 10 Holdings %
Top 10 Hldgs %
95.95%
Holding
20
New
3
Increased
5
Reduced
6
Closed
1
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$5.75M |
| 2 |
Pacific Biosciences
PACB
|
$2.24M |
| 3 |
BIOL
Biolase, Inc.
BIOL
|
$2.23M |
| 4 |
Accuray
ARAY
|
$1.89M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$1.64M |
Top Sells
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$57.1M |
| 2 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$12.4M |
| 3 |
Precigen
PGEN
|
$9.39M |
| 4 |
QuidelOrtho
QDEL
|
$4.48M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$2.81M |
Sector Composition
| 1 | Healthcare | 81.95% |
| 2 | Consumer Staples | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
1
DELISTED
TESARO, Inc.
TSRO
| $133M | 21.83% | 1,030,825 -21,754 | -2% | -$2.81M |
|
|
MZOR
2
DELISTED
Mazor Robotics Ltd.
MZOR
| $110M | 17.98% | 2,219,800 -251,578 | -10% | -$12.4M |
|
|
3
QuidelOrtho
QDEL
$1.95B
| $106M | 17.45% | 2,425,416 -102,138 | -4% | -$4.48M |
|
|
AXDX
4
DELISTED
Accelerate Diagnostics
AXDX
| $106M | 17.33% | 4,706,637 -12,889 | -0.3% | -$289K |
|
|
5
Pacific Biosciences
PACB
$393M
| $45.6M | 7.48% | 8,686,455 +427,075 | +5% | +$2.24M |
|
6
Opko Health
OPK
$1.1B
| $24.9M | 4.09% | 3,636,760 | – | – |
|
|
AMRN
7
Amarin Corp
AMRN
$311M
| $22.1M | 3.62% | 6,303,307 -121,049 | -2% | -$424K |
|
|
VRML
8
DELISTED
Vermillion, Inc.
VRML
| $17.7M | 2.9% | 9,825,289 +583,333 | +6% | +$1.05M |
|
|
BIOL
9
DELISTED
Biolase, Inc.
BIOL
| $11M | 1.81% | 18,320,650 +3,698,600 | +25% | +$2.23M |
|
|
AGEN
10
Agenus
AGEN
$133M
| $7.04M | 1.16% | 1,597,392 | – | – |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $7.04M | 1.15% | 369,403 +77,023 | +26% | +$1.47M |
|
|
ADAP
12
Adaptimmune Therapeutics
ADAP
$15.6M
| $5.75M | 0.94% | +701,861 | New | +$5.75M |
|
|
13
Precigen
PGEN
$1.34B
| $3.71M | 0.61% | 195,000 -494,002 | -72% | -$9.39M |
|
|
CFRX
14
DELISTED
ContraFect Corporation
CFRX
| $2.42M | 0.4% | 2,182,032 +1,000,000 | +85% | +$1.11M |
|
15
Biogen
BIIB
$19.4B
| $1.99M | 0.33% | 6,368 | – | – |
|
|
16
Accuray
ARAY
$157M
| $1.89M | 0.31% | +473,256 | New | +$1.89M |
|
|
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.64M | 0.27% | +64,373 | New | +$1.64M |
|
18
AquaBounty Technologies
AQB
$4.58M
| $87K | 0.01% | 12,204 | – | – |
|
19
Vivani Medical
VANI
$68.1M
| $61K | 0.01% | 50,804 | – | – |
|
|
NXTM
20
DELISTED
NxStage Medical Inc.
NXTM
| – | – | -2,276,106 | Closed | -$57.1M |
|